151 – 160 of 168
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
- Contribution to journal › Scientific review
-
Mark
Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer.
- Contribution to journal › Scientific review
-
Mark
Skewing Towards Neuroendocrine Phenotype in High Grade or High Stage Androgen-Responsive Primary Prostate Cancer
- Contribution to journal › Letter
-
Mark
Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project
- Contribution to journal › Article
- 2004
-
Mark
Microbial flora in ileal and colonic neobladders.
- Contribution to journal › Article
-
Mark
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio
- Contribution to journal › Article
-
Mark
Evidence-based Urology - A utopia?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Neutral Third Party versus Treating Institution for Evaluating Quality of Life after Radical Cystectomy.
- Contribution to journal › Article
- 2003
-
Mark
Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: A Nordic study
- Contribution to journal › Article
-
Mark
Expression and immunolocalisation of neutral endopeptidase in prostate cancer
- Contribution to journal › Article
